CUSIP: 503459604
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM PAR $.0001 2
-
Total 13F shares
-
20,191,489
-
Share change
-
+1,286,068
-
Total reported value
-
$86,007,135
-
Put/Call ratio
-
95%
-
Price per share
-
$4.26
-
Number of holders
-
74
-
Value change
-
+$5,502,028
-
Number of buys
-
42
-
Number of sells
-
31
Quarterly Holders Quick Answers
What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2020
-
Previous quarter:
Q1 2020
Recent filing periods for CUSIP 503459604:
Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2020
As of 30 Jun 2020,
LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,191,489 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, BOXER CAPITAL, LLC, MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, and Alyeska Investment Group, L.P..
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.